DIMA Trademark

Trademark Overview


On Tuesday, December 2, 2025, a trademark application was filed for DIMA with the United States Patent and Trademark Office. The USPTO has given the DIMA trademark a serial number of 99525706. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, April 15, 2026. This trademark is owned by DIMA Biotechnology LTD. The DIMA trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Reagents for therapeutic, diagnostic and scientific research, namely, recombinant proteins and conjugates of recombinant proteins, monoclonal antibodies and conjugates of monoclonal antibodies; assay reagents and ELISA kits for biomedical research; Genetically engineered complementary DNA (cDNA); Engineered stable cell lines; Chemicals for protein extraction and purification; IgG antibodies from immunized animals and humans; Biological preparations for the treatment of multiple myeloma, blood tumor and solid tumor; Synthesized DNAs; Synthesized peptides for scientific purposes

Scientific, technological and medical research services, namely, services for protein expression, protein and antibody engineering, protein and antibody chemical conjugation, monoclonal and polyclonal antibody development, cell line development, assay development, In Vivo animal study, In Vitro cell based assays, gene cloning, and genome editing
dima

General Information


Serial Number99525706
Word MarkDIMA
Filing DateTuesday, December 2, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, April 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesReagents for therapeutic, diagnostic and scientific research, namely, recombinant proteins and conjugates of recombinant proteins, monoclonal antibodies and conjugates of monoclonal antibodies; assay reagents and ELISA kits for biomedical research; Genetically engineered complementary DNA (cDNA); Engineered stable cell lines; Chemicals for protein extraction and purification; IgG antibodies from immunized animals and humans; Biological preparations for the treatment of multiple myeloma, blood tumor and solid tumor; Synthesized DNAs; Synthesized peptides for scientific purposes
Goods and ServicesScientific, technological and medical research services, namely, services for protein expression, protein and antibody engineering, protein and antibody chemical conjugation, monoclonal and polyclonal antibody development, cell line development, assay development, In Vivo animal study, In Vitro cell based assays, gene cloning, and genome editing

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 2, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDIMA Biotechnology LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWuhan, Hubei Province 430070
CN

Trademark Events


Event DateEvent Description
Tuesday, December 2, 2025NEW APPLICATION ENTERED
Tuesday, December 2, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 6, 2026ASSIGNED TO EXAMINER
Tuesday, April 14, 2026NON-FINAL ACTION WRITTEN
Tuesday, April 14, 2026NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED